CoQ10 prices in the United States showed a steady rebound in early February, recovering after a period of slight softness at the start of the year. Market participants attributed the recovery to cautious procurement by nutraceutical and pharmaceutical buyers combined with stable production and import flows, which helped maintain predictable inventories and prevent abrupt fluctuations. Throughout January, trading remained largely range-bound, with discretionary channels such as cosmetics and personal care continuing to adopt a conservative approach to restocking. In early February, renewed buying from core sectors provided upward momentum, signaling a gradual return of market confidence while overall sentiment remained measured. Looking ahead, prices are expected to maintain moderate upward pressure, influenced primarily by buyer procurement patterns and any shifts in import timing. While sudden large-scale replenishment could create additional gains, the combination of steady supply and selective buying suggests that the market will likely continue with a balanced, gradually strengthening trend.
